MATHIEU, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 331.678
NA - Nord America 14.108
AS - Asia 4.840
SA - Sud America 1.015
AF - Africa 90
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 351.752
Nazione #
IT - Italia 327.273
US - Stati Uniti d'America 13.980
CN - Cina 2.046
SG - Singapore 1.823
UA - Ucraina 1.167
NL - Olanda 1.094
BR - Brasile 828
SE - Svezia 694
DE - Germania 398
VN - Vietnam 385
GB - Regno Unito 343
FI - Finlandia 334
FR - Francia 124
KR - Corea 120
CA - Canada 79
IN - India 78
AR - Argentina 70
JP - Giappone 51
ID - Indonesia 47
HK - Hong Kong 45
RU - Federazione Russa 44
BD - Bangladesh 43
IQ - Iraq 39
BE - Belgio 34
ES - Italia 31
CO - Colombia 30
TR - Turchia 28
EC - Ecuador 24
MX - Messico 24
PL - Polonia 23
IR - Iran 22
ZA - Sudafrica 19
AT - Austria 18
MA - Marocco 18
IL - Israele 16
UZ - Uzbekistan 15
PE - Perù 14
PY - Paraguay 14
EG - Egitto 13
CZ - Repubblica Ceca 12
GR - Grecia 12
PK - Pakistan 12
TN - Tunisia 12
AU - Australia 11
CH - Svizzera 11
VE - Venezuela 11
IE - Irlanda 10
CL - Cile 9
DK - Danimarca 9
SA - Arabia Saudita 9
KE - Kenya 8
BG - Bulgaria 7
BO - Bolivia 7
JO - Giordania 7
NP - Nepal 7
UY - Uruguay 7
BY - Bielorussia 6
ET - Etiopia 6
LT - Lituania 6
DZ - Algeria 5
HR - Croazia 5
LB - Libano 5
LU - Lussemburgo 5
DO - Repubblica Dominicana 4
EU - Europa 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LV - Lettonia 4
MU - Mauritius 4
NZ - Nuova Zelanda 4
RO - Romania 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
HN - Honduras 3
JM - Giamaica 3
LK - Sri Lanka 3
NO - Norvegia 3
OM - Oman 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
GE - Georgia 2
GT - Guatemala 2
KW - Kuwait 2
PA - Panama 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
SO - Somalia 2
TW - Taiwan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CV - Capo Verde 1
Totale 351.740
Città #
Cagliari 205.439
Uta 120.956
Fairfield 1.539
Woodbridge 1.338
Amsterdam 1.067
Ashburn 995
Chandler 921
Houston 893
Dallas 856
Singapore 840
Ann Arbor 768
Boardman 711
Wilmington 642
Jacksonville 604
Seattle 558
Cambridge 494
Nyköping 462
Beijing 386
Dearborn 377
Los Angeles 213
Nanjing 206
Hefei 188
Boston 178
Buffalo 153
Helsinki 139
Shanghai 137
Santa Clara 131
Dong Ket 128
Seoul 112
Milan 95
Ho Chi Minh City 92
New York 89
Redwood City 86
San Diego 84
Shenyang 83
The Dalles 74
Nanchang 71
São Paulo 70
Guangzhou 68
London 53
Rome 53
Hebei 52
Jiaxing 48
Toronto 48
Hanoi 46
Tianjin 46
Changsha 45
Munich 45
Mountain View 42
Hong Kong 41
Phoenix 38
Sassari 35
Chicago 34
Tokyo 34
Belo Horizonte 32
Norwalk 32
Verona 32
Washington 32
Redondo Beach 30
Jinan 29
Orange 29
Brussels 26
Brooklyn 25
Auburn Hills 23
Falls Church 23
Nuremberg 21
Zhengzhou 21
Council Bluffs 20
Kunming 20
San Mateo 20
Baghdad 19
Rio de Janeiro 19
Warsaw 19
Stockholm 18
Columbus 16
Pune 16
Detroit 15
Ningbo 15
Dhaka 14
San Francisco 14
Tashkent 14
Augusta 13
Buenos Aires 13
Denver 13
Curitiba 12
Jakarta 12
Ribeirão Preto 12
Atlanta 11
Brasília 11
Florence 11
Haiphong 11
Hangzhou 11
Johannesburg 11
Manchester 11
Wuhan 11
Ardabil 10
Chennai 10
Dublin 10
Elk Grove Village 10
Goiânia 10
Totale 343.710
Nome #
Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology 118.776
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.714
Overexpression of the cytokine BAFF and autoimmunity risk 4.056
An optimized infrastructure for deferred telemonitoring of home rehabilitation in chronic rheumatic patients 3.909
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.131
Home tele-rehabilitation for rheumatic patients: impact and satisfaction of care analysis 3.073
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.028
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 2.988
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.877
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.792
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.777
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.764
Apparatus, a system and a relating method for local or remote rehabilitation and functional evaluation of the hands 2.632
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 2.593
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.573
A Device for Local or Remote Monitoring of Hand Rehabilitation Sessions for Rheumatic Patients 2.563
Physical activity levels and health-related quality of life in young Italian population 2.364
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.327
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.308
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study 2.305
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes 2.262
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.258
null 2.245
Polymyalgia rheumatica: an autoinflammatory disorder? 2.217
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 2.186
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.162
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.161
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 2.130
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus 2.103
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia 2.100
An Integrated Portable Device for the Hand Functional Assessment in the Clinical Practice 2.074
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.072
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 2.048
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 1.998
The ankylosing spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients 1.959
Re: Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination 1.927
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.927
Ankylosing spondylitis: A trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia 1.924
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.902
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.898
Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report 1.898
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 1.818
null 1.791
Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation 1.787
A portable real-time monitoring system for kinesitherapic hand rehabilitation exercises 1.774
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.755
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.665
Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia : Implications for disease pathogensis 1.651
Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al. 1.632
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.597
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 1.591
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study 1.588
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.572
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 1.569
null 1.562
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.514
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 1.469
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology 1.451
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 1.447
Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients 1.439
null 1.431
Genetics of Behcet's disease in Sardinia: two distinct extended HLA haplotypes harbour the B*51 allele in the normal population and in patients 1.426
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.423
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.416
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 1.371
Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset 1.331
Comparison of early vs. delayed anakinra treatment in patients with adult onset still's disease and effect on clinical and laboratory outcomes 1.305
Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy 1.282
null 1.241
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 1.240
The growing role of cardiac magnetic resonance imagin in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis 1.234
Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a real-life setting 1.174
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 1.123
Vitamin D levels and potential impact in systemic sclerosis 1.098
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.098
Association between the presence of c-ANCA and abnormal cerebral single photon emission computed tomography (SPECT) in patients with systemic lupus erythematosus 1.062
Global microRNA profiling of peripheral blood mononuclear cells in patients with Behçet's disease 1.058
The origin of Behçet’s disease geoepidemiology: possible role of a dual microbial - driven genetic selection. 1.033
Post-Streptococcal Reactive Arthritis Associated With Group G Streptococcal Pharyngitis 1.013
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.003
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNF-alpha agents in axial spondyloarthritis 986
Multiple Septic Bursitis and Spontaneous Achilles Tendon Tear in Systemic Lupus Erythematosus 983
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 981
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 974
Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice 969
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 905
null 902
Physical Activity Levels And Health-related Quality Of Life In Italian University Students 902
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 898
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 890
Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al 874
Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. 870
Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum? 865
Calcitonin decreases lithium plasma levels in man. Preliminary report 853
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 834
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia 829
Familial chilblain and late contractural arachnodactyly: A novel association? 824
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study 808
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 784
Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography. A myocardial echostress scleroderma pattern 782
Totale 296.748
Categoria #
all - tutte 434.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 434.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121.869 0 0 0 0 0 6.248 5.362 2.918 1.175 2.135 2.223 1.808
2021/202211.587 1.011 907 666 639 911 893 729 683 1.203 1.008 1.486 1.451
2022/202316.051 1.637 1.842 1.641 1.235 1.471 1.550 715 2.097 1.095 926 1.127 715
2023/202423.751 1.187 772 885 1.656 2.156 3.234 3.323 3.923 982 1.467 2.304 1.862
2024/2025162.043 10.164 11.446 7.398 120.906 2.504 2.417 3.913 251 477 1.522 450 595
2025/20265.622 652 706 1.532 1.302 939 491 0 0 0 0 0 0
Totale 352.467